Our Offerings
By Industry By Function
About Us
Our Viewpoint
NEW
 Senior Management Experts Panel Global Consultants Press Releases Blog
Infographics Market Insights Case Studies Illustrations In The Press
Contact Us
The Business Research Company Logo
Reports Store
Top 50 Healthcare Market Reports
NEW
 Top 50 Non-Healthcare Market Reports
NEW
 Opportunities And Strategies Reports Aerospace And Defense Agriculture Chemicals Construction
Electrical And Electronics Financial Services Food And Beverages Healthcare Services Hospitality Information Technology Machinery Media
Medical Equipment Metal And Mineral Mining Oil And Gas Paper, Plastics, Rubber, Wood And Textile Pharmaceuticals Professional Services Recreation
Retail And Wholesale Services Social Services Transport Transport Services Utilities Veterinary Healthcare Filter Reports by Trends
NEW
Market Intelligence Platform
About GMM Global Forecast
NEW
 Mega Trends Analysis
Consultancies Corporate Planning & Strategy Academic Financial Services Legal Services
Pricing Methodology Sources FAQ Press Coverage
Customized Research
Find Customers Optimise Your Marketing Mix Evaluate Competitors Identify Market Opportunities Develop Products And Services
Distributor And Partner Research Plan Finances Streamline Your Operations Devise Market Entry Strategy Explore Custom Research Packages
NEW
Continuous Research
Desk Research Research Reports Senior Executive Interviews Consumer Research Market Sizing And Forecasts
Company Information Analytics And Data Visualization Research Automation Web Crawling And Spidering AI-Empowered Research Services
Request Proposal
Ribonucleic Acid Interference (RNAi) Technology Global Market Report 2025
Download Free Sample Buy Now
Global Ribonucleic Acid Interference (RNAi) Technology Market Report 2025

Report Price : $4490.00

Pages : 250

Format : PDF

Published : December 2025

Delivery Time : 2-3 Business Days

Purchase This Report Download Sample PDF
Purchase This Report

Ribonucleic Acid Interference (RNAi) Technology Global Market Report 2025

By Product (Micro Ribonucleic Acid (miRNA), Small Interfering Ribonucleic Acid (siRNA), Other Products), By Delivery Method (Viral Vectors, Nanoparticles, Chemical Modifications, Physical Methods), By Application (Therapeutics, Drug Discovery, Agriculture, Diagnostics), By End-User (Pharmaceutical And Biotechnology Companies, Academic And Research Institutes, Contract Research Organizations (CROs) And Contract Manufacturing Organizations (CMOs)) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Ribonucleic Acid Interference (RNAi) Technology Market Overview

• Ribonucleic Acid Interference (RNAi) Technology market size has reached to $3.82 billion in 2024

• Expected to grow to $7.96 billion in 2029 at a compound annual growth rate (CAGR) of 15.7%

• Growth Driver: Increasing Demand For Targeted Therapeutics Fueling The Growth Of The Market Due To Advancements In Precision Medicine

• Market Trend: Strategic Funding Boosts Advancement Of RNAi Therapeutics

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Ribonucleic Acid Interference (RNAi) Technology Market?

Ribonucleic acid interference (RNAi) technology is a biological process that regulates gene expression by using small RNA molecules to silence specific messenger RNA (mRNA) sequences. It is used to regulate gene activity, allowing scientists to silence or reduce the production of targeted proteins. it helps to inhibit the expression of disease-related genes, making it a powerful tool for genetic research, drug development, and therapeutic applications.

The main products of ribonucleic acid interference (RNAi) technology are micro ribonucleic acid (miRNA), small interfering ribonucleic acid (siRNA), and others. Micro ribonucleic acid (miRNA) refers to short, non-coding ribonucleic acid molecules that bind complementary messenger ribonucleic acid sequences to repress translation or promote degradation, thereby fine-tuning gene expression. The various delivery methods include Viral Vectors, nanoparticles, chemical modifications and physical methods and are applied across various fields such as therapeutics, drug discovery, agriculture and diagnostics. It is widely used by pharmaceutical and biotechnology companies, academic and research institutes and contract research organizations (CROs) and contract manufacturing organizations (CMOs).

Ribonucleic Acid Interference (RNAi) Technology Market Size and growth rate 2025 to 2029: Graph

What Is The Ribonucleic Acid Interference (RNAi) Technology Market Size 2025 And Growth Rate?

The ribonucleic acid interference (RNAi) technology market size has grown rapidly in recent years. It will grow from $3.82 billion in 2024 to $4.43 billion in 2025 at a compound annual growth rate (CAGR) of 16.1%. The growth in the historic period can be attributed to increasing genomics research funding, rising prevalence of genetic and rare diseases, growing use of ribonucleic acid (RNA) interference in functional genomics studies, increasing pharmaceutical company interest in gene-silencing modalities, and rising academic-industry collaborations.

What Is The Ribonucleic Acid Interference (RNAi) Technology Market Growth Forecast?

The ribonucleic acid interference (RNAi) technology market size is expected to see rapid growth in the next few years. It will grow to $7.96 billion in 2029 at a compound annual growth rate (CAGR) of 15.7%. The growth in the forecast period can be attributed to increasing clinical trial initiations and patient enrollment, rising partnerships, mergers and licensing agreements, growing healthcare spending on specialty and precision medicines, increasing demand for personalized therapies, and rising burden of oncology and chronic liver diseases. Major trends in the forecast period include advancements in lipid nanoparticle delivery systems, development of n-acetylgalactosamine conjugate liver targeting, optimization of self-delivering small interfering ribonucleic acid platforms, artificial intelligence-assisted design and off-target minimization for small interfering ribonucleic acid, and progress in exosome-mediated and cell-penetrating peptide delivery.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

What’s The Trade War Impact On Pharmaceuticals Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

How Is The Ribonucleic Acid Interference (RNAi) Technology Market Segmented?

1) By Product: Micro Ribonucleic Acid (miRNA), Small Interfering Ribonucleic Acid (siRNA), Other Products

2) By Delivery Method: Viral Vectors, Nanoparticles, Chemical Modifications, Physical Methods

3) By Application: Therapeutics, Drug Discovery, Agriculture, Diagnostics

4) By End-User: Pharmaceutical And Biotechnology Companies, Academic And Research Institutes, Contract Research Organizations (CROs) And Contract Manufacturing Organizations (CMOs)

Subsegments:

1) By Micro Ribonucleic Acid (miRNA): Micro Ribonucleic Acid Mimics, Micro Ribonucleic Acid Inhibitors, Micro Ribonucleic Acid Expression Vectors, Micro Ribonucleic Acid Profiling And Quantification Kits

2) By Small Interfering Ribonucleic Acid (siRNA): Small Interfering Ribonucleic Acid Synthetic Duplexes, Small Interfering Ribonucleic Acid Dicer Substrate Molecules, Small Interfering Ribonucleic Acid Self Delivering Conjugates, Small Interfering Ribonucleic Acid N Acetylgalactosamine Conjugates

3) By Other Products: Short Hairpin Ribonucleic Acid Expression Constructs, Ribonucleic Acid Interference Screening Libraries, Ribonucleic Acid Interference Transfection Reagents, Micro Ribonucleic Acid And Small Interfering Ribonucleic Acid Research Kits

What Is Driving The Ribonucleic Acid Interference (RNAi) Technology Market? Increasing Demand For Targeted Therapeutics Fueling The Growth Of The Market Due To Advancements In Precision Medicine

The increasing demand for targeted therapeutics is expected to propel the growth of the ribonucleic acid interference (RNAi) technology market going forward. Targeted therapies are treatments that specifically target and inhibit molecular abnormalities in cancer or other diseases to improve treatment precision and minimize harm to healthy cells. The rising focus on targeted therapies is primarily driven by the advancements in precision medicine, which enables personalized, more effective treatments based on individual genetic profiles. Ribonucleic Acid Interference (RNAi) Technology enhances demand for targeted therapeutics by enabling precise gene silencing to treat genetic and rare diseases. It supports the development of highly specific and effective treatments, driving innovation in personalized medicine. For instance, in December 2024, according to the American Society of Gene & Cell Therapy (ASGCT), a US-based non-profit medical and scientific organization, the Food and Drug Administration (FDA) approved 6 gene therapy products in 2023, up from 5 approvals in 2022. Therefore, the increasing demand for targeted therapeutics is driving the growth of the ribonucleic acid interference (RNAi) technology industry.

Who Are The Major Players In The Global Ribonucleic Acid Interference (RNAi) Technology Market?

Major companies operating in the ribonucleic acid interference (rnai) technology market are F. Hoffmann-La Roche AG, Merck KGaA, Novartis AG, Thermo Fisher Scientific Inc., Danaher Corporation, Revvity Inc., QIAGEN N.V., Alnylam Pharmaceuticals Inc., Ionis Pharmaceuticals Inc., GenScript Biotech Corporation, Promega Corporation, Arrowhead Pharmaceuticals Inc., Silence Therapeutics plc, Creative Biolabs Inc., Bioneer Corporation, Genevant Sciences Ltd., Gradalis Inc., Altogen Labs LLC, Sirnaomics Inc., Altogen Biosystems Inc.

What Are The Key Trends Of The Global Ribonucleic Acid Interference (RNAi) Technology Market? Strategic Funding Boosts Advancement Of RNAi Therapeutics

Major companies operating in the ribonucleic acid interference (RNAi) technology market are focusing on platform integration, such as strategic funding and support, to streamline the development, delivery, and commercialization of RNA interference (RNAi) therapeutics, enabling a sustainable pipeline of multiple programs across diverse disease areas. Strategic funding and support refer to securing investment and resources from venture capital, industry partners, and other stakeholders to accelerate research, development, and commercialization of RNA interference (RNAi) therapeutics. For instance, in October 2024, City Therapeutics Inc., a US-based biopharmaceutical company, received $135 million in Series A financing led by ARCH Venture Partners, with participation from other leading life sciences investors, to lead the future of RNA interference (RNAi)-based medicine. This funding will develop RNAi-based medicine by leveraging its proprietary lipid nanoparticle (LNP) delivery platform, designed to target tissues beyond the liver with high precision. This platform aims to overcome a key historical limitation in the field, enabling the development of therapies for a wider range of genetic disorders.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Ribonucleic Acid Interference (RNAi) Technology Market? Novartis Acquires DTx Pharma To Boost RNAi Capabilities

In July 2023, Novartis AG, a Switzerland-based pharmaceutical company, acquired DTx Pharma Inc. for an undisclosed amount. With this acquisition, Novartis AG aims to strengthen its RNAi therapeutic capabilities and expand its neuromuscular disease portfolio using DTx Pharma’s FALCON delivery platform. DTx Pharma Inc. is a US-based preclinical-stage biotechnology company specializing in RNA interference (RNAi) technology for developing RNAi-based therapeutics.

What Is The Regional Outlook For The Global Ribonucleic Acid Interference (RNAi) Technology Market?

North America was the largest region in the ribonucleic acid interference (RNAi) technology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Ribonucleic Acid Interference (RNAi) Technology Market?

The ribonucleic acid interference (RNAi) technology consists of revenues earned by entities by providing services such as gene silencing services, custom ribonucleic acid (RNA) synthesis, oligonucleotide design, ribonucleic acid (RNA) sequencing, target validation, functional genomics screening, data analysis, drug discovery support, delivery system optimization, and molecular assay development. The market value includes the value of related goods sold by the service provider or included within the service offering. The RNA interference (RNAi) technology market also includes sales of microRNA mimics, transfection reagents, ribonucleic acid (RNA) delivery kits, plasmid vectors, assay kits, cell lines, reagents and buffers, and laboratory consumables. Values in this market are ‘factory gate’ values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Ribonucleic Acid Interference (RNAi) Technology Industry?

The ribonucleic acid interference (rnai) technology market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the ribonucleic acid interference (rnai) technology industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Ribonucleic Acid Interference (RNAi) Technology Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $4.43 billion
Revenue Forecast In 2034 $7.96 billion
Growth Rate CAGR of 16.1% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered Product, Delivery Method, Application, End-User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled F. Hoffmann-La Roche AG, Merck KGaA, Novartis AG, Thermo Fisher Scientific Inc., Danaher Corporation, Revvity Inc., QIAGEN N.V., Alnylam Pharmaceuticals Inc., Ionis Pharmaceuticals Inc., GenScript Biotech Corporation, Promega Corporation, Arrowhead Pharmaceuticals Inc., Silence Therapeutics plc, Creative Biolabs Inc., Bioneer Corporation, Genevant Sciences Ltd., Gradalis Inc., Altogen Labs LLC, Sirnaomics Inc., Altogen Biosystems Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Ribonucleic Acid Interference (RNAi) Technology Market Characteristics

3. Ribonucleic Acid Interference (RNAi) Technology Market Trends And Strategies

4. Ribonucleic Acid Interference (RNAi) Technology Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Ribonucleic Acid Interference (RNAi) Technology Growth Analysis And Strategic Analysis Framework

5.1. Global Ribonucleic Acid Interference (RNAi) Technology PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Ribonucleic Acid Interference (RNAi) Technology Market Growth Rate Analysis

5.4. Global Ribonucleic Acid Interference (RNAi) Technology Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Ribonucleic Acid Interference (RNAi) Technology Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Ribonucleic Acid Interference (RNAi) Technology Total Addressable Market (TAM)

6. Ribonucleic Acid Interference (RNAi) Technology Market Segmentation

6.1. Global Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Micro Ribonucleic Acid (miRNA)

Small Interfering Ribonucleic Acid (siRNA)

Other Products

6.2. Global Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Viral Vectors

Nanoparticles

Chemical Modifications

Physical Methods

6.3. Global Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Therapeutics

Drug Discovery

Agriculture

Diagnostics

6.4. Global Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Pharmaceutical And Biotechnology Companies

Academic And Research Institutes

Contract Research Organizations (CROs) And Contract Manufacturing Organizations (CMOs)

6.5. Global Ribonucleic Acid Interference (RNAi) Technology Market, Sub-Segmentation Of Micro Ribonucleic Acid (miRNA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Micro Ribonucleic Acid Mimics

Micro Ribonucleic Acid Inhibitors

Micro Ribonucleic Acid Expression Vectors

Micro Ribonucleic Acid Profiling And Quantification Kits

6.6. Global Ribonucleic Acid Interference (RNAi) Technology Market, Sub-Segmentation Of Small Interfering Ribonucleic Acid (siRNA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Small Interfering Ribonucleic Acid Synthetic Duplexes

Small Interfering Ribonucleic Acid Dicer Substrate Molecules

Small Interfering Ribonucleic Acid Self Delivering Conjugates

Small Interfering Ribonucleic Acid N Acetylgalactosamine Conjugates

6.7. Global Ribonucleic Acid Interference (RNAi) Technology Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Short Hairpin Ribonucleic Acid Expression Constructs

Ribonucleic Acid Interference Screening Libraries

Ribonucleic Acid Interference Transfection Reagents

Micro Ribonucleic Acid And Small Interfering Ribonucleic Acid Research Kits

7. Ribonucleic Acid Interference (RNAi) Technology Market Regional And Country Analysis

7.1. Global Ribonucleic Acid Interference (RNAi) Technology Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Ribonucleic Acid Interference (RNAi) Technology Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Ribonucleic Acid Interference (RNAi) Technology Market

8.1. Asia-Pacific Ribonucleic Acid Interference (RNAi) Technology Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Ribonucleic Acid Interference (RNAi) Technology Market

9.1. China Ribonucleic Acid Interference (RNAi) Technology Market Overview

9.2. China Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Ribonucleic Acid Interference (RNAi) Technology Market

10.1. India Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Ribonucleic Acid Interference (RNAi) Technology Market

11.1. Japan Ribonucleic Acid Interference (RNAi) Technology Market Overview

11.2. Japan Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Ribonucleic Acid Interference (RNAi) Technology Market

12.1. Australia Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Ribonucleic Acid Interference (RNAi) Technology Market

13.1. Indonesia Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Ribonucleic Acid Interference (RNAi) Technology Market

14.1. South Korea Ribonucleic Acid Interference (RNAi) Technology Market Overview

14.2. South Korea Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Ribonucleic Acid Interference (RNAi) Technology Market

15.1. Western Europe Ribonucleic Acid Interference (RNAi) Technology Market Overview

15.2. Western Europe Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Ribonucleic Acid Interference (RNAi) Technology Market

16.1. UK Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Ribonucleic Acid Interference (RNAi) Technology Market

17.1. Germany Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Ribonucleic Acid Interference (RNAi) Technology Market

18.1. France Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Ribonucleic Acid Interference (RNAi) Technology Market

19.1. Italy Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Ribonucleic Acid Interference (RNAi) Technology Market

20.1. Spain Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Ribonucleic Acid Interference (RNAi) Technology Market

21.1. Eastern Europe Ribonucleic Acid Interference (RNAi) Technology Market Overview

21.2. Eastern Europe Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Ribonucleic Acid Interference (RNAi) Technology Market

22.1. Russia Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Ribonucleic Acid Interference (RNAi) Technology Market

23.1. North America Ribonucleic Acid Interference (RNAi) Technology Market Overview

23.2. North America Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Ribonucleic Acid Interference (RNAi) Technology Market

24.1. USA Ribonucleic Acid Interference (RNAi) Technology Market Overview

24.2. USA Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Ribonucleic Acid Interference (RNAi) Technology Market

25.1. Canada Ribonucleic Acid Interference (RNAi) Technology Market Overview

25.2. Canada Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Ribonucleic Acid Interference (RNAi) Technology Market

26.1. South America Ribonucleic Acid Interference (RNAi) Technology Market Overview

26.2. South America Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Ribonucleic Acid Interference (RNAi) Technology Market

27.1. Brazil Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Ribonucleic Acid Interference (RNAi) Technology Market

28.1. Middle East Ribonucleic Acid Interference (RNAi) Technology Market Overview

28.2. Middle East Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Ribonucleic Acid Interference (RNAi) Technology Market

29.1. Africa Ribonucleic Acid Interference (RNAi) Technology Market Overview

29.2. Africa Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Ribonucleic Acid Interference (RNAi) Technology Market Competitive Landscape And Company Profiles

30.1. Ribonucleic Acid Interference (RNAi) Technology Market Competitive Landscape

30.2. Ribonucleic Acid Interference (RNAi) Technology Market Company Profiles

30.2.1. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Ribonucleic Acid Interference (RNAi) Technology Market Other Major And Innovative Companies

31.1. Revvity Inc.

31.2. QIAGEN N.V.

31.3. Alnylam Pharmaceuticals Inc.

31.4. Ionis Pharmaceuticals Inc.

31.5. GenScript Biotech Corporation

31.6. Promega Corporation

31.7. Arrowhead Pharmaceuticals Inc.

31.8. Silence Therapeutics plc

31.9. Creative Biolabs Inc.

31.10. Bioneer Corporation

31.11. Genevant Sciences Ltd.

31.12. Gradalis Inc.

31.13. Altogen Labs LLC

31.14. Sirnaomics Inc.

31.15. Altogen Biosystems Inc.

32. Global Ribonucleic Acid Interference (RNAi) Technology Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Ribonucleic Acid Interference (RNAi) Technology Market

34. Recent Developments In The Ribonucleic Acid Interference (RNAi) Technology Market

35. Ribonucleic Acid Interference (RNAi) Technology Market High Potential Countries, Segments and Strategies

35.1 Ribonucleic Acid Interference (RNAi) Technology Market In 2029 - Countries Offering Most New Opportunities

35.2 Ribonucleic Acid Interference (RNAi) Technology Market In 2029 - Segments Offering Most New Opportunities

35.3 Ribonucleic Acid Interference (RNAi) Technology Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Ribonucleic Acid Interference (RNAi) Technology Market, Sub-Segmentation Of Micro Ribonucleic Acid (miRNA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Ribonucleic Acid Interference (RNAi) Technology Market, Sub-Segmentation Of Small Interfering Ribonucleic Acid (siRNA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Ribonucleic Acid Interference (RNAi) Technology Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Ribonucleic Acid Interference (RNAi) Technology Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Ribonucleic Acid Interference (RNAi) Technology Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Asia-Pacific, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: China, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: India, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Japan, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Australia, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Indonesia, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: South Korea, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Western Europe, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: UK, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Germany, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: France, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Italy, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Spain, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Eastern Europe, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Russia, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: North America, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: USA, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: Canada, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: South America, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Brazil, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Middle East, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Africa, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: F. Hoffmann-La Roche AG Financial Performance
  • Table 79: Merck KGaA Financial Performance
  • Table 80: Novartis AG Financial Performance
  • Table 81: Thermo Fisher Scientific Inc. Financial Performance
  • Table 82: Danaher Corporation Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Ribonucleic Acid Interference (RNAi) Technology Market, Sub-Segmentation Of Micro Ribonucleic Acid (miRNA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Ribonucleic Acid Interference (RNAi) Technology Market, Sub-Segmentation Of Small Interfering Ribonucleic Acid (siRNA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Ribonucleic Acid Interference (RNAi) Technology Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Ribonucleic Acid Interference (RNAi) Technology Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Ribonucleic Acid Interference (RNAi) Technology Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Asia-Pacific, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: China, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: India, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Japan, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Australia, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Indonesia, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: South Korea, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Western Europe, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: UK, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Germany, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: France, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Italy, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Spain, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Eastern Europe, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Russia, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: North America, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: USA, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: Canada, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: South America, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Brazil, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Middle East, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Africa, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: F. Hoffmann-La Roche AG Financial Performance
  • Figure 79: Merck KGaA Financial Performance
  • Figure 80: Novartis AG Financial Performance
  • Figure 81: Thermo Fisher Scientific Inc. Financial Performance
  • Figure 82: Danaher Corporation Financial Performance

Cyclin-Dependent Kinase (CDK) 4/6 Inhibitor Drugs Market Forecast 2025–2034: Trends Reshaping Demand, Investment, and Innovation

Read More About Cyclin-Dependent Kinase (CDK) 4/6 Inhibitor Drugs Market Forecast 2025–2034: Trends Reshaping Demand, Investment, and Innovation

Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Projected to Reach $47.74 Billion by 2029 at a CAGR of 30.7%

Read More About Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Projected to Reach $47.74 Billion by 2029 at a CAGR of 30.7%

$8.21 Billion Forecast for Exocrine Pancreatic Insufficiency (EPI) Therapeutics And Diagnostics Market by 2029, Backed by Demand and Innovation

Read More About $8.21 Billion Forecast for Exocrine Pancreatic Insufficiency (EPI) Therapeutics And Diagnostics Market by 2029, Backed by Demand and Innovation

Fentanyl Market Forecast Reaching $22.03 Billion by 2029 at 6.5% CAGR

Read More About Fentanyl Market Forecast Reaching $22.03 Billion by 2029 at 6.5% CAGR

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

Read More About A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

Read More About A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

Read More About A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

Discover key trends and market dynamics in the Mycobacterium Tuberculosis Market with 2025 insights from The Business Research Company.

Read More About Discover key trends and market dynamics in the Mycobacterium Tuberculosis Market with 2025 insights from The Business Research Company.

CRISPR Technology Market - By Product Type (Cas9 And GRNA, Design Tools, Plasmid And Vector), By End-User (Academic Research Organizations, Biopharmaceutical Companies, Agricultural Biotechnology Companies, Contract Rese...

View Report

Nucleic Acid Based Gene Therapy Global Market Report 2025 – By Technology (Anti-Sence and Anti-Gene, Short Inhibitory Sequences, Gene Transfer Therapy, Nucleoside Analogs, Ribozymes, Aptamers, Other Technologies), By App...

View Report

Ribonucleic Acid (RNA) Sequencing Global Market Report 2025 – By Product Type (Instruments, Reagents And Kits, Software), By Technology (Single Molecule Based Sequencing, Sequence By Synthesis Technology, Nanopore Sequen...

View Report

Nucleic Acid Isolation & Purification Global Market Report 2025 – By Type( Plasmid DNA Isolation and Purification, Total RNA Isolation and Purification, Circulating Nucleic Acid Isolation and Purification, Genomic DNA Is...

View Report

Ribose-Nucleic Acid (RNA)-Based Therapeutics Global Market Report 2025 – By Type (RNA Interference (RNAi), RNA Antisense), By Technology (Enabling Technology, Enabled Technology), By Therapeutic Area (Oncology, Genetic D...

View Report

Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Global Market Report 2025 – By Type (Capping Agents, Nucleotides, Plasmid DNA, Other Types), By Applications (Therapeutics Production, Vaccine Production, Other A...

View Report

Automated Nucleic Acid Extraction Devices Global Market Report 2025 – By Type (Instruments, Kits, Consumables), By Product (Fully Automated, Semi-Automated), By End User (Hospitals, Diagnostic Centers, Forensic Laborator...

View Report

Recombinant DNA Technology Global Market Report 2025 – By Product Type( Recombinant Protein Drugs, Vaccines, Genetically Modified Crops, Expression Systems, Cell and Gene Therapy, Gene Editing ), By Component Type( Expre...

View Report

Frequently Asked Questions

Ribonucleic acid interference (RNAi) technology is a biological process that regulates gene expression by using small RNA molecules to silence specific messenger RNA (mRNA) sequences. It is used to regulate gene activity, allowing scientists to silence or reduce the production of targeted proteins. it helps to inhibit the expression of disease-related genes, making it a powerful tool for genetic research, drug development, and therapeutic applications. For further insights on this market, request a sample here

The market major growth driver - Increasing Demand For Targeted Therapeutics Fueling The Growth Of The Market Due To Advancements In Precision Medicine. For further insights on this market, request a sample here

The ribonucleic acid interference (RNAi) technology market size has grown rapidly in recent years. It will grow from $3.82 billion in 2024 to $4.43 billion in 2025 at a compound annual growth rate (CAGR) of 16.1%. The growth in the historic period can be attributed to increasing genomics research funding, rising prevalence of genetic and rare diseases, growing use of ribonucleic acid (RNA) interference in functional genomics studies, increasing pharmaceutical company interest in gene-silencing modalities, and rising academic-industry collaborations. The ribonucleic acid interference (RNAi) technology market size is expected to see rapid growth in the next few years. It will grow to $7.96 billion in 2029 at a compound annual growth rate (CAGR) of 15.7%. The growth in the forecast period can be attributed to increasing clinical trial initiations and patient enrollment, rising partnerships, mergers and licensing agreements, growing healthcare spending on specialty and precision medicines, increasing demand for personalized therapies, and rising burden of oncology and chronic liver diseases. Major trends in the forecast period include advancements in lipid nanoparticle delivery systems, development of n-acetylgalactosamine conjugate liver targeting, optimization of self-delivering small interfering ribonucleic acid platforms, artificial intelligence-assisted design and off-target minimization for small interfering ribonucleic acid, and progress in exosome-mediated and cell-penetrating peptide delivery. For further insights on this market, request a sample here

The ribonucleic acid interference (rnai) technology market covered in this report is segmented –
1) By Product: Micro Ribonucleic Acid (miRNA), Small Interfering Ribonucleic Acid (siRNA), Other Products
2) By Delivery Method: Viral Vectors, Nanoparticles, Chemical Modifications, Physical Methods
3) By Application: Therapeutics, Drug Discovery, Agriculture, Diagnostics
4) By End-User: Pharmaceutical And Biotechnology Companies, Academic And Research Institutes, Contract Research Organizations (CROs) And Contract Manufacturing Organizations (CMOs) Subsegments:
1) By Micro Ribonucleic Acid (miRNA): Micro Ribonucleic Acid Mimics, Micro Ribonucleic Acid Inhibitors, Micro Ribonucleic Acid Expression Vectors, Micro Ribonucleic Acid Profiling And Quantification Kits
2) By Small Interfering Ribonucleic Acid (siRNA): Small Interfering Ribonucleic Acid Synthetic Duplexes, Small Interfering Ribonucleic Acid Dicer Substrate Molecules, Small Interfering Ribonucleic Acid Self Delivering Conjugates, Small Interfering Ribonucleic Acid N Acetylgalactosamine Conjugates
3) By Other Products: Short Hairpin Ribonucleic Acid Expression Constructs, Ribonucleic Acid Interference Screening Libraries, Ribonucleic Acid Interference Transfection Reagents, Micro Ribonucleic Acid And Small Interfering Ribonucleic Acid Research Kits For further insights on this market, request a sample here

North America was the largest region in the ribonucleic acid interference (RNAi) technology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ribonucleic acid interference (rnai) technology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Major companies operating in the ribonucleic acid interference (rnai) technology market are F. Hoffmann-La Roche AG, Merck KGaA, Novartis AG, Thermo Fisher Scientific Inc., Danaher Corporation, Revvity Inc., QIAGEN N.V., Alnylam Pharmaceuticals Inc., Ionis Pharmaceuticals Inc., GenScript Biotech Corporation, Promega Corporation, Arrowhead Pharmaceuticals Inc., Silence Therapeutics plc, Creative Biolabs Inc., Bioneer Corporation, Genevant Sciences Ltd., Gradalis Inc., Altogen Labs LLC, Sirnaomics Inc., Altogen Biosystems Inc. . For further insights on this market, request a sample here.

Major trends in this market include Strategic Funding Boosts Advancement Of RNAi Therapeutics. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us
Global Ribonucleic Acid Interference (RNAi) Technology Market Report 2025

Wait, we have a special offer for you! ✋

Get your exclusive 20% discount only on the Global Market Reports now using the code ONLINE20*

YES, get the discount! No, I'd pay the full price

*Copy paste the discount code in the cart

Back to top WhatsApp icon